Hamps Bio Limited, a key player in the ethical marketing and distribution of pharmaceutical formulations, is set to launch its IPO with a fresh issue amounting to ₹6.22 Crores. The subscription for the IPO opens on December 13, 2024, and closes on December 17, 2024. This IPO includes 12.20 lakh shares priced at ₹51 per equity share, with the Market Capitalisation of ₹22.21 Crores at the issue price.

The Grey Market Premium (GMP) for Hamps Bio IPO is ₹14, suggesting a potential listing gain of 27.45%. The lot size is 2,000 shares, with retail investors required to invest a minimum of ₹1,02,000 for one lot. High-Net-Worth Individuals (HNIs) will need to invest a minimum of ₹2,04,000 for two lots. This IPO is being managed by MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED as the book-running lead manager and BIGSHARE SERVICES PVT LTD as the registrar. Pure Broking Private Limited is the Market Maker.

Hamps Bio IPO Objectives

The proceeds from the IPO will be utilized for several key purposes:

• ₹359.00 Lakh will be allocated for the purchase of plant and machinery for the FMCG division.
• ₹50.00 Lakh will be used for enhancing the visibility and brand awareness.
• ₹151.87 Lakh will be used for general corporate purposes.

Financial Performance of Hamps Bio

For the period ending October 31, 2024, the company's Revenues from operations were ₹436.42 Lakh, showing growth over the past years. In FY 2024, the company reported EBITDA of ₹75.11 Lakh and a Profit After Tax (PAT) of ₹34.08 Lakh. This reflects a healthy financial performance and suggests that Hamps Bio is well-positioned for growth.

Hamps Bio IPO Valuation

The pre-issue EPS for Hamps Bio stands at ₹1.76, with a post-issue EPS of ₹1.15. The pre-issue P/E ratio is 28.98, and the post-issue P/E ratio is 44.37, indicating that the IPO is fairly priced. The company's Return on Capital Employed (ROCE) for FY24 is 18.31%, and its Return on Equity (RoE) stands at 21.14%, both strong indicators of financial health.

With the Grey Market Premium showing potential listing gains and the solid financials of the company, Hamps Bio IPO presents an opportunity for risky investors to apply for potential listing gains.

The Upcoming IPOs in this week and coming weeks are NACDAC Infrastructure, Transrail Lighting, Mamata Machinery, Identical Brain Studios, Rosmerta Digital, Indo Farm, DAM Capital and Avanse Financial.

The Current active IPO is and International Gemmological, Hamps Bio, Yash Highvoltage and Inventurus Knowledge.

For more details on upcoming IPOs, you can visit our page at Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and stay updated with the latest news on IPO updates on Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance Saathi. Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates. Start your Stock Market Journey and Apply in IPO by opening a Free Demat Account in Choice Broking FinX.